1. Home
  2. WKSP vs MRKR Comparison

WKSP vs MRKR Comparison

Compare WKSP & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$1.35

Market Cap

12.3M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.37

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKSP
MRKR
Founded
2003
N/A
Country
United States
United States
Employees
81
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
24.5M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
WKSP
MRKR
Price
$1.35
$1.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$9.25
$11.25
AVG Volume (30 Days)
434.8K
157.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$94.77
N/A
Revenue Next Year
$127.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.81
52 Week High
$4.90
$4.07

Technical Indicators

Market Signals
Indicator
WKSP
MRKR
Relative Strength Index (RSI) 38.57 41.01
Support Level $1.00 $0.83
Resistance Level $1.63 $1.44
Average True Range (ATR) 0.18 0.11
MACD 0.01 -0.01
Stochastic Oscillator 55.56 13.92

Price Performance

Historical Comparison
WKSP
MRKR

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: